Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-54819
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Improper limitation of a pathname to a restricted directory ('Path Traversal') issue exists in SS1 Ver.16.0.0.10 and earlier (Media version:16.0.0a and earlier). If this vulnerability is exploited, legitimate files may be overwritten by a remote authenticated attacker.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
对路径名的限制不恰当(路径遍历)
Source: NVD (National Vulnerability Database)
Vulnerability Title
DOS & CO SS1 路径遍历漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
DOS & CO SS1是日本DOS & CO公司的一个资产管理工具。 DOS & CO SS1 16.0.0.10及之前版本存在路径遍历漏洞,该漏洞源于路径名限制不当,可能导致远程经验证攻击者覆盖合法文件。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
DOS Co., Ltd.SS1 Ver.16.0.0.10 and earlier (Media version:16.0.0a and earlier) -
DOS Co., Ltd.SS1 Cloud Ver.2.1.3 and earlier -
II. Public POCs for CVE-2025-54819
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-54819
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2025-54819

No comments yet


Leave a comment